Patterns of treatment failure for PD-(L)1 refractory extensive-stage small cell lung cancer in continued PD-(L)1 treatment

Background: Although immunotherapy greatly extends overall survival (OS) of patients with extensive-stage small cell lung cancer (ES-SCLC), a number of patients develop immunotherapy resistance (IR). Patterns of failure in ES-SCLC are not clarified. Our study aims to explore the clinical pattern of...

Full description

Bibliographic Details

Published in:	Translational Oncology
Main Authors:	Li Liu, Tong Liu, Xingwen Wang, Jianbo Wang, Jun Wang, Meng Yuan, Yunxin Yang, Yingying Zhang, Hang Wang, Pingping Hu, Jiandong Zhang
Format:	Article
Language:	English
Published:	Elsevier 2023-07-01
Subjects:	Extensive-stage small cell lung cancer (ES-SCLC) Immunotherapy Patterns of failure
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523323000736